Compounds > cytarabine

cytarabine and Hand-Foot Syndrome

cytarabine has been researched along with Hand-Foot Syndrome in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baker, SD; Bishop, MW; Cheng, C; Jeha, S; Karol, SE; Pappo, AS; Pui, CH; Relling, MV; Rubnitz, JE; Sandlund, JT; Smith, C; Stewart, CF; Yang, W1
Hu, X; Jiang, W; Jiang, Y; Jin, G; Liu, R; Luan, Y; Wu, J1
Aoi, M; Kitamura, K; Sakurada, H; Sugimura, Y; Tachi, T; Teramachi, H; Yamamura, M; Yuge, M1
Alzghari, SK; Cable, CT; Herrington, JD; Seago, SE1
Bozkurt, C; Dogru, M; Kocaoglu, AC; Ozmen, S1
Hwang, YY; Kwong, YL; Trendell-Smith, NJ; Yeung, CK1

Other Studies

6 other study(ies) available for cytarabine and Hand-Foot Syndrome

ArticleYear
Palmar-plantar erythrodysesthesia syndrome following treatment with high-dose methotrexate or high-dose cytarabine.
    Cancer, 2017, Sep-15, Volume: 123, Issue:18

    Topics: Adolescent; Age Distribution; Analysis of Variance; Child; Child, Preschool; Cytarabine; Databases, Factual; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Hand-Foot Syndrome; Hematologic Neoplasms; Humans; Incidence; Infusions, Intravenous; Male; Methotrexate; Multivariate Analysis; Odds Ratio; Retrospective Studies; Risk Assessment; Severity of Illness Index; Sex Distribution

2017
A preclinical evaluation of cytarabine prodrug nanofibers assembled from cytarabine-lauric acid conjugate toward solid tumors.
    International journal of pharmaceutics, 2018, Dec-01, Volume: 552, Issue:1-2

    Topics: Animals; Antimetabolites, Antineoplastic; Cell Line, Tumor; Cytarabine; Drug Carriers; Female; Hand-Foot Syndrome; Humans; Lauric Acids; Mice, Inbred BALB C; Nanofibers; Neoplasms; Prodrugs; Stomatitis; Tumor Burden

2018
[A Case of a Multidisciplinary Team Approach to Serious Hand-Foot Syndrome Induced by High-Dose Cytarabine Therapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2016, Volume: 43, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Erythema; Female; Hand-Foot Syndrome; Humans; Idarubicin; Leukemia, Myeloid, Acute; Patient Care Team; Treatment Outcome

2016
Severe palmar-plantar erythrodysesthesia and aplasia in an adult undergoing re-induction treatment with high-dose cytarabine for acute myelogenous leukemia: a possible drug interaction between posaconazole and cytarabine.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2017, Volume: 23, Issue:6

    Topics: Cytarabine; Drug Interactions; Erythema; Female; Hand-Foot Syndrome; Humans; Leukemia, Myeloid, Acute; Triazoles; Young Adult

2017
Probable cytarabine-induced acral erythema: report of 2 pediatric cases.
    Journal of pediatric hematology/oncology, 2013, Volume: 35, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cytarabine; Etoposide; Female; Hand-Foot Syndrome; Humans; Leukemia, Myeloid, Acute; Mitoxantrone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis

2013
Fatal palmar-plantar erythrodysesthesia after clofarabine and cytarabine chemotherapy.
    Acta haematologica, 2012, Volume: 128, Issue:3

    Topics: Adenine Nucleotides; Antineoplastic Agents; Arabinonucleosides; Clofarabine; Cytarabine; Fatal Outcome; Hand-Foot Syndrome; Humans; Leukemia, Myeloid, Acute

2012